Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$10.2 million.

  • Organogenesis Holdings' Cash from Financing Activities fell 50864.64% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 37086.92%. This contributed to the annual value of $27.6 million for FY2024, which is 60203.45% up from last year.
  • Organogenesis Holdings' Cash from Financing Activities amounted to -$10.2 million in Q3 2025, which was down 50864.64% from -$288000.0 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Cash from Financing Activities registered a high of $33.6 million during Q4 2024, and its lowest value of -$10.2 million during Q3 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$1.1 million (2023), whereas its average is $334000.0.
  • As far as peak fluctuations go, Organogenesis Holdings' Cash from Financing Activities tumbled by 563076.92% in 2023, and later surged by 199358.47% in 2024.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Cash from Financing Activities stood at -$917000.0 in 2021, then plummeted by 104.47% to -$1.9 million in 2022, then rose by 5.23% to -$1.8 million in 2023, then surged by 1993.58% to $33.6 million in 2024, then crashed by 130.33% to -$10.2 million in 2025.
  • Its Cash from Financing Activities stands at -$10.2 million for Q3 2025, versus -$288000.0 for Q2 2025 and -$2.1 million for Q1 2025.